BNIPL Antibody (OTI2E8)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-44724
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # OTI2E8
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Human recombinant protein fragment corresponding to amino acids 1-203 of human BNIPL(NP_612122) produced in E.coli.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Description
Novus Biologicals Mouse BNIPL Antibody (OTI2E8) (NBP3-44724) is a monoclonal antibody validated for use in WB. All Novus Biologicals antibodies are covered by our 100% guarantee.
Applications for BNIPL Antibody (OTI2E8)
Application
Recommended Usage
Western Blot
1:500-2000
Formulation, Preparation, and Storage
Purification
>95%
Reconstitution
For reconstitution, we recommend adding 100uL distilled water to a final antibody concentration of about 1 mg/mL. To use this carrier-free antibody for conjugation experiment, we strongly recommend performing another round of desalting process.
Formulation
Lyophilized powder ( 1X PBS, pH 7.3,)
Preservative
8% Trehalose
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20 degrees C. Avoid freeze/thaw cycles.
Background: BNIPL
Alternate Names
bcl-2/adenovirus E1B 19 kDa-interacting protein 2-like protein, BCL2/adenovirus E1B 19kD interacting protein like, BNIP-2 similar, BNIPL-1, BNIPL-2, BNIP-S, PP753
Gene Symbol
BNIPL
Additional BNIPL Products
Product Specific Notices for BNIPL Antibody (OTI2E8)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...